Background It is difficult to diagnose lymph node metastasis in biliary and pancreas carcinomas before surgery. Aim The aim of this study was to assess the utility of the combination of multi-detector computed tomographic (MDCT) findings and serum carbohydrate antigen (CA)19-9 level in the diagnosis of lymph node metastasis in biliary and pancreas carcinomas. Methods The subjects were 139 patients with biliary and pancreas carcinomas who underwent surgical resection. We calculated the positive predictive values (PPV), sensitivities, specificities, positive likelihood ratios (PLR) and accuracies of diagnosis by MDCT alone, serum CA19-9 level alone, and their combination. Results The PPV and sensitivity were higher for node metastasis in hepatoduodenal ligament than in common hepatic artery (CHA) or para-aortic region (PAR).
Introduction
Lymph node metastasis is a prognostic factor in patients with biliary or pancreas carcinoma who undergo surgical resection [1, 2] . Preoperatively, node status determined by image studies offers useful information for assessment of node metastasis and choice of radical surgery. However, preoperative image diagnosis does not always match the pathological findings. Several groups have reported that the diagnostic accuracy of imaging studies for lymph node metastasis remains unsatisfactory even with the application of multi-detector row computed tomography (MDCT) [3] [4] [5] , magnetic resonance imaging (MRI) [6, 7] and positron emission tomography (PET) [8] in patients with pancreato-biliary carcinoma. Thus, in patients with lymphadenopathy detected by these imaging modalities, particularly the para-aortic lymph nodes, the choice of type and extent of surgery remains difficult due to the low positive predictive values (PPV), and the lymph node status can only be confirmed properly during laparotomy. On the other hand, serum tumor markers, such as carbohydrate antigen (CA)19-9, can be used as a sensitive diagnostic tool for cancer, and their levels are associated with advanced carcinoma including tumor extension and lymph node metastasis [9, 10] . However, the accuracy of diagnosis of lymph node metastasis is also limited when such markers are used alone. Based on this background, we hypothesized in our study that the combination of imaging studies and highly sensitive laboratory markers improves the accuracy of preoperative diagnosis of lymph node metastasis from pancreato-biliary carcinomas, and the selection of the most appropriate treatment approach. To test our hypothesis, we assessed first the diagnostic accuracy of CT imaging and serum CA19-9 separately, and then evaluated the combination of these two diagnostic modalities. We analyzed the CT findings and serum CA19-9 levels in consecutive patients with biliary and pancreatic carcinoma who had undergone surgical resection after 2000, and the diagnostic accuracy of each method was compared with the histopathological findings of regional lymph node metastasis at a single cancer institute.
Materials and Methods

Patients and Preoperative Assessment
Subjects comprised 139 consecutive patients (93 men, 46 women) with biliary or pancreas head carcinoma who underwent hepatectomy or pancreaticoduodenectomy between 2000 and 2008 at the Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Hospital. The Ethics Review Board of our university approved the study protocol.
Between 2000 and 2008, multi-detector row CT was applied for the assessment and diagnosis of the extent of tumor spread and lymphadenopathy in the abdomen. Enhanced CT in the arterial and portal phases using contrast media was used in all cases. The apparatus was a MDCT with 4 detectors (Somatom Plus Volume Zoom; Siemens, Malvern, PA). After plain CT, a dual-phase enhanced CT was performed. Using an automatic infuser pump, 100 ml of non-ionized contrast media was injected intravenously at 3 ml/s. The arterial phase at 35 s and delayed phase at 100-120 s after injection were exposed. The beam width was 2.5 mm, slice width was 7 mm, and the interval of reconstruction ranged between 7 and 10 mm.
Positive nodes represented lymph nodes that could be detected on the enhanced CT. Lymph node metastasis was evaluated in 3 regions: (1) the hepato-duodenal ligament (#12); (2) the common hepatic artery (#8); and (3) the paraaortic region (#16) according to the Classification of Biliary Tract Carcinoma by the Japanese Society of Biliary Surgery and the Classification of Pancreatic Carcinoma by the Japan Pancreas Society [11, 12] . An experienced radiologist (I.S.) reviewed the diagnosis of lymph node metastasis by CT and measured the maximum size of the lymph node. On admission to the hospital, blood samples were obtained before the morning meal for measurement of serum CA19-9 (Elecsys Ò CA19-9 II; Roche Diagnostics, Indianapolis, IN). In patients with obstructive jaundice, blood samples were obtained when total bilirubin level was \2 mg/dl.
Evaluation of Histopathological Changes and Serum CA19-9 Levels
The surgically resected specimens were fixed in 10% formalin and the lymph nodes were sectioned serially at 5-mm intervals, stained with hematoxylin and eosin and examined microscopically. All histological slides were reviewed by an experienced pathologist (T.H.). The numbering of region of lymph nodes and T category (=primary tumor invasion) were based on the Classification of Biliary Tract Carcinoma by the Japanese Society of Biliary Surgery and Classification of Pancreatic Carcinoma by the Japan Pancreas Society [11, 12] . The CT findings and serum CA19-9 levels were analyzed according to the histopathological findings. The cut-off level for abnormal serum CA19-9 was set at 37 U/ml (upper limit of normal range).
Statistical Analysis
The Mann-Whitney U test was used for comparison of categorical data. PPV (%), sensitivity (%), specificity (%), accuracy, and positive likelihood ratio (PLR) were calculated using 2 9 2 tables. The impact of likelihood was considered 'large' when [10, 'moderate' for 5-10, 'small' for 2-5, 'tiny' for 1-2, and 'no change' for 1. Continuous data were expressed as mean ± SD. Data of different groups were compared using one-way analysis of variance (ANOVA) followed by Dunnet's multiple comparison test. A two-tailed P value of \0.05 was considered significant. Statistical analyses were performed using Statistica software (StatSoft, Tulsa, OK).
Results
The mean age of the 139 patients was 67 ± 11 years (range, 30-87 years). Of the 139 patients, hilar bile duct carcinoma was present in 25 (18.0%), distal bile duct carcinoma in 29 (20.9%), ampullary carcinoma in 13 (9.4%), gallbladder carcinoma in 28 (20.1%), and pancreas head carcinoma in 44 (31.6%). We retrospectively reviewed data of these 139 patients, focusing on lymph node metastasis. In this cohort, 75 patients (33.1%) underwent pancreaticoduodenectomy, 46 (33.1%) had hepatic resection with or without resection of the extrahepatic bile duct, seven (5.0%) underwent liver resection ? pancreaticoduodenectomy, five (3.6%) underwent cholecystectomy, four (2.9%) had resection of the extrahepatic bile duct and two (1.4%) underwent probe laparotomy with lymph node biopsy. Postoperative tumor recurrence at 11 months of median follow-up was observed in 23 patients (nine lymph node metastasis, six liver metastasis, three local recurrence, and five peritoneal carcinomatosis) while 116 (83.5%) patients had no such recurrence. Five patients died during hospitalization and five others died of tumor-unrelated diseases. Table 1 shows the correlation between CT findings and histologically-confirmed node metastasis in each region. The PPV and sensitivity were higher for node metastasis in the hepatoduodenal ligament compared to those in the common hepatic artery or para-aortic region. The specificity, accuracy and PLR were highest in the common hepatic artery among the three regions. However, the impact of PLR was not considered large or moderate in any region. When analyses were conducted for biliary and pancreas carcinoma separately (Table 2) , the results for biliary carcinoma were similar to those for the entire group. The impact of PLR in the common hepatic artery was moderate in biliary carcinomas. However, in pancreatic carcinoma, PLR was slightly higher (small impact) in the para-aortic region compared to the other two regions, although the specificity and accuracy were highest for the common hepatic region.
The sensitivity of serum CA19-9 level for node metastasis was higher than that of CT findings in each region (Table 3 ). However, the PPV, specificity, accuracy and PLR of serum CA19-9 level for node metastasis in each region were lower than those of CT findings. Similar tendencies were noted for both biliary and pancreas carcinoma (Table 4) . However, the impact of PLR by CA19-9 level was considered tiny in all regions. Table 5 shows serum CA19-9 levels according to T category in biliary and pancreas carcinomas. Serum CA19-9 tended to be high in T3 and T4 categories but this was not significant in each carcinoma. Table 6 shows the combination of CT findings and serum CA19-9 level for the diagnosis of lymph node metastases in each region. The combination of positive CT results and higher CA19-9 level had the highest positive rate for node metastasis compared to the other three combinations of CT findings and serum CA19-9 level. This tendency was similar in each node region for both biliary and pancreas carcinoma (Table 7) . Table 8 shows the regional distribution of unmatched node metastasis between the CT findings and histopathologically-confirmed node metastasis. In biliary carcinomas, pseudo-negative node metastasis on CT tended to be seen for nodes around the common hepatic artery, nodes around the bile duct and para-aortic nodes below the right renal vein. Pseudo-positive node metastases on CT tended to be seen for para-aortic nodes below the right renal vein. In pancreatic carcinomas, pseudo-negative node metastasis tended to be marked in marginal nodes of the pancreatic head, nodes around the supra-mesenteric vein and para-aortic nodes below the right renal vein. No specific tendencies were identified for pseudo-positive node metastases on CT.
Discussion
Preoperative imaging assessment of regional lymph node metastasis in solid carcinomas is essential for making decisions about surgical indications and perioperative management [13] . In this regard, the diagnostic value of various imaging modalities including the high-powered CT, remains node limited at present. Several reports have examined the relationship between size or morphological structure of the lymph nodes on imaging and histopathologically-confirmed metastasis in hepatopancreatobiliary malignancies, but the accuracy of diagnosis using imaging studies remains unsatisfactory [3, 4, 6, 14, 15] . The first aim of this study was to clarify the status of the diagnostic accuracy for node metastasis in pancreato-biliary carcinomas in order to find related limitations or problems. In the next step, to improve the low diagnostic accuracy of node metastasis, we combined a surrogate marker with imaging studies. The size of lymph nodes detected by imaging is the most significant parameter for the diagnosis of metastasis [3, 6] . A size of 10 mm was applied as a cut-off level by Watadani et al. [15] . Noji et al. reported that PPV was only 31% for 10 mm in biliary carcinoma, and a cut-off level of [16 mm was used to increase the PPV to [50% for diagnosis of node metastasis [3] . Thus, the accuracy of imaging studies increases with increased node size. In our series, we also examined node size using a cut-off of PPV positive predictive value, PLR positive likelihood ratio 10 mm; the specificity increased in nodes [10 mm compared with that in nodes \10 mm, similar to the report of Watadani et al. [15] (data not shown in our study). However, the sensitivity and PPV were less than 50% in each regional lymph node using size [10 mm. Few lymph nodes measuring [16 mm were detected in our series. Even in lymph nodes \10 mm in size, histopathologicallyconfirmed lymph node metastasis was common in our cohort. Noji et al. [3] reported that approximately 30% of the lymph nodes were histopathologically positive at cutoff levels of 6, 8 and 10 mm. In this regard, no correlation was reported between lymph node size and histopathological metastasis in other solid tumors [16, 17] . Therefore, we did not apply a cut-off size in our study because such cut-off level of node size was probably not suitable for positive prediction based on the above studies. Other investigators have used the morphological characteristics or enhancement patterns using contrast media for the diagnosis of lymph node metastasis with biliary carcinoma [3, 4, 6, 15, 18] . Changes in the diagnostic accuracy might not be marked and heterogeneous findings in lymph nodes are rare [13, 18] . In our series, heterogeneous findings of lymph node detected by enhanced CT were also rare as well. Therefore, tumor size and morphology were considered not useful for improvement of the diagnosis of node metastasis. The diagnostic accuracy may differ for each regional lymph node. Previous studies focused on the diagnosis of para-aortic lymph node metastasis [6, 14] . Confirmation of lymph node metastasis in the para-aortic region is important surgically with respect to the extent of surgical intervention for biliary and pancreatic carcinoma [13] . Noji et al. [14] reported a lower accuracy of node metastasis in this region compared to other regions. In our series, the diagnostic accuracy of node metastasis also differed according to the region and also according to the type of tumor (i.e., biliary and pancreatic carcinomas). The PPV for lymph node metastasis was lowest for the para-aortic region with biliary carcinomas, although the PPV of this region was similar to other regions with pancreatic carcinoma. In cases of pancreatic carcinoma, node metastasis is more likely to occur due to the proximity of this organ, which might lead to higher PPV compared to biliary carcinoma. According to previous reports, the para-aortic lymph nodes are considered to be the neighboring regional lymph nodes for pancreatic carcinoma [19] . The PLR of a positive test tells us how well a positive test result does by comparing its performance when the disease is present compared with when it is absent. The PLR is a tool used to incorporate the sensitivity and specificity of a test into a single measure. Since the sensitivity and specificity are fixed characteristics of the test itself, the likelihood ratio is independent of the prevalence of the disease in the population. In our results, the highest PLR was observed in the common hepatic arterial region compared to other regions; however, even the impact of PLR in this region was still statistically small, reflecting the low power of MDCT for the diagnosis of node metastasis. These results indicated that the diagnosis of node metastasis even by the advanced imaging modality is difficult at this stage.
The diagnostic accuracy of MDCT in our study was similar to that reported previously [3, 4, 14, 15] . PET and high-resolution MRI have been considered additional modalities to improve diagnostic accuracy [6] [7] [8] 20 ], although the PPV was similar to that of CT. Schwartz et al. [7] reported that the accuracy was similar for CT and MRI. Furukawa et al. [8] indicated the limitations of resolution of PET-CT imaging for lymph node metastasis. In our series, MRI and PET-CT were not always performed to gain more information of tumor spread. The diagnosis of lymph node involvement by these imaging modalities was not superior to that of CT in this study as well as previous reports [6] [7] [8] 20 ], although precise analyses of the diagnostic power of CT and other modalities were not performed.
Recently, endoscopic ultrasound guided-fine needle aspiration (EUS-FNA) has been used for the diagnosis of solid tumors or lymphadenopathy around the digestive tract [21, 22] . This modality showed high sensitivity and predictive value over 80% for the diagnosis of malignancies [22] . This diagnostic accuracy is significantly higher than in our study. The EUS-FNA is also a promising diagnostic tool for lymph node swelling in pancreato-biliary carcinomas. At this stage, however, the above procedures are not used routinely for the diagnosis of lymph node metastasis. Improvement of preoperative assessment by imaging studies is thus limited at this stage. For preoperative assessment of tumor extension, tumor markers such as a serum CA19-9 level have been used in biliary and pancreas carcinomas [23, 24] . The diagnosis of lymph node metastasis using this marker alone is almost impossible. However, we hypothesized that the combination of image findings and serum tumor marker levels would increase the diagnostic accuracy of node metastasis, since CA19-9 level is related to malignant tumor behavior [25] . The results showed increase in PPV in cases with positive imaging results and levels of CA19-9 above the normal range. In our study, we set up the cut-off level of CA19-9 to be [37 U/ml although the median CA19-9 value in our series was 49 U/ml. Marrelli et al. [26] reported that the use of a cut-off value of 90 U/ml, selected based on receiver operating characteristic (ROC) analysis, improved the diagnostic accuracy after biliary drainage. Thus, the use of a CA19-9 level higher than 37 U/ml might be necessary to determine the extent of malignant behavior. Further analysis in a large number of subjects would be necessary to establish the most appropriate cut-off value for the diagnosis of node metastasis. Brockmann et al. reported that CA19-9 correlated with lymph node status in gallbladder carcinoma [9] . The impact of PLR by measuring CA19-9 level was tiny; however, we hypothesized that this marker improves the diagnostic power of CT imaging for node metastasis because of its higher sensitivity than CT imaging in our study. Previous studies indicated that CA19-9 levels were influenced by primary tumor spread and related cholangitis [9, 10, 27] . In our patients with obstructive jaundice, biliary drainage was preoperatively performed and biliary congestion or inflammation was controlled as much as possible. With respect to primary tumor extension, serum CA19-9 tended to be increased in advanced stages but was not significantly affected by category. In our study, the correlation between node metastasis and CA19-9 was more significant compared to T category, although the influence of tumor Station number of regional lymph node was according to the Classification of Biliary Tract Carcinoma by the Japanese Society of Biliary Surgery and the Classification of Pancreatic Carcinoma by the Japan Pancreas Society [11, 12] 6 infra-pyloric, 7 left gastric artery, 8a anterior hepatic artery, 8p posterior hepatic artery, 9 celiac artery, 11 splenic artery, 12b bile duct, 12p portal vein, 12a hepatic artery, 13 retro-pancreatic head, 14 supra-mesenteric artery, 15 middle colic artery, 16a2 inferior paraaorta (supra-right renal vein), 16b1 middle para-aorta (infra-right renal vein), 17 anterior pancreatic head extension or cholangitis could not be analyzed properly. The lymph node metastasis may show the higher degree of malignant behavior in comparison with tumor extension in the biliary and pancreatic carcinomas. Therefore, CA 19-9 might be better correlated with node metastasis than T stage as described above. It is necessary to clarify these relationship between histological findings and the reliable tumor markers in further studies. The combination of high CA19-9 level and a positive node by MDCT increased the positive rate, indicating that CA19-9 level adds value in the diagnosis of lymph node metastasis in cases with imaging-positive lymphadenopathy. The combination of MDCT and CA19-9 level may be more useful for the diagnosis of node metastasis compared with that by MDCT alone. In our study, CEA level was also examined routinely but its sensitivity and PLR were lower than those of CA19-9 level (17-28% and \1.5, respectively). The diagnostic accuracy of other tumor markers have been reported recently [28, 29] , and the most useful markers for the diagnosis of node metastasis need to be established. Improvement of diagnosis of lymph node metastasis should lead to changes in tumor management. At this stage, we have confirmed the accuracy of preoperative CT and high CA19-9 levels in the diagnosis of lymph node metastasis.
This study showed the distribution of unmatched lymph node metastasis between imaging and histopathology. The results showed frequent involvement of the para-gastric lymph nodes and lymph nodes surrounding the supra-mesenteric artery (SMA). Although we did not focus on these regions in the analysis, such node metastases could not be detected even by high-resolution MDCT in these cases. In fact, the prevalence of para-gastric lymph node metastasis is reported to be uncommon in these carcinomas [30] . In pancreatic carcinomas, lymphadenectomy of the lymph nodes surrounding the SMA is a key step in surgical resection.
In this study we were able to show preliminary data regarding the diagnostic accuracy of lymph node metastasis at a single cancer institute; further study in a larger cohort is necessary to validate these results in the future. In conclusion, our evaluation indicated that the combination of serum CA19-9 level and high-resolution MDCT is useful for the preoperative diagnosis of lymph node metastasis in biliary and pancreas carcinomas.
